Unveiling the role of hypoxia-inducible factor 2alpha in osteoporosis: Implications for bone health

Ling-Ling Wang; Zhan-Jin Lu; Shun-Kui Luo; Yun Li; Zhe Yang; Hong-Yun Lu

doi:10.4252/wjsc.v16.i4.389

Unveiling the role of hypoxia-inducible factor 2alpha in osteoporosis: Implications for bone health

World J Stem Cells. 2024 Apr 26;16(4):389-409. doi: 10.4252/wjsc.v16.i4.389.

Authors

Ling-Ling Wang¹, Zhan-Jin Lu², Shun-Kui Luo², Yun Li³, Zhe Yang⁴, Hong-Yun Lu⁵

Affiliations

¹ Department of Gerontology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, Guangdong Province, China.
² Department of Endocrinology and Metabolism, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, Guangdong Province, China.
³ Guangdong Provincial Key Laboratory of Biomedical Imaging, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, Guangdong Province, China.
⁴ Department of Endocrinology and Metabolism, Zhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University, the First Hospital Affiliated with Medical College of Macao University of Science and Technology), Zhuhai 519000, Guangdong Province, China.
⁵ Department of Endocrinology and Metabolism, Zhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University, the First Hospital Affiliated with Medical College of Macao University of Science and Technology), Zhuhai 519000, Guangdong Province, China. luhongyun@jnu.edu.cn.

Abstract

Background: Osteoporosis (OP) has become a major public health problem worldwide. Most OP treatments are based on the inhibition of bone resorption, and it is necessary to identify additional treatments aimed at enhancing osteogenesis. In the bone marrow (BM) niche, bone mesenchymal stem cells (BMSCs) are exposed to a hypoxic environment. Recently, a few studies have demonstrated that hypoxia-inducible factor 2alpha (HIF-2α) is involved in BMSC osteogenic differentiation, but the molecular mechanism involved has not been determined.

Aim: To investigate the effect of HIF-2α on the osteogenic and adipogenic differentiation of BMSCs and the hematopoietic function of hematopoietic stem cells (HSCs) in the BM niche on the progression of OP.

Methods: Mice with BMSC-specific HIF-2α knockout (Prx1-Cre;Hif-2α^fl/fl mice) were used for in vivo experiments. Bone quantification was performed on mice of two genotypes with three interventions: Bilateral ovariectomy, semilethal irradiation, and dexamethasone treatment. Moreover, the hematopoietic function of HSCs in the BM niche was compared between the two mouse genotypes. In vitro, the HIF-2α agonist roxadustat and the HIF-2α inhibitor PT2399 were used to investigate the function of HIF-2α in BMSC osteogenic and adipogenic differentiation. Finally, we investigated the effect of HIF-2α on BMSCs via treatment with the mechanistic target of rapamycin (mTOR) agonist MHY1485 and the mTOR inhibitor rapamycin.

Results: The quantitative index determined by microcomputed tomography indicated that the femoral bone density of Prx1-Cre;Hif-2α^fl/fl mice was lower than that of Hif-2α^fl/fl mice under the three intervention conditions. In vitro, Hif-2α^fl/fl mouse BMSCs were cultured and treated with the HIF-2α agonist roxadustat, and after 7 d of BMSC adipogenic differentiation, the oil red O staining intensity and mRNA expression levels of adipogenesis-related genes in BMSCs treated with roxadustat were decreased; in addition, after 14 d of osteogenic differentiation, BMSCs treated with roxadustat exhibited increased expression of osteogenesis-related genes. The opposite effects were shown for mouse BMSCs treated with the HIF-2α inhibitor PT2399. The mTOR inhibitor rapamycin was used to confirm that HIF-2α regulated BMSC osteogenic and adipogenic differentiation by inhibiting the mTOR pathway. Consequently, there was no significant difference in the hematopoietic function of HSCs between Prx1-Cre;Hif-2α^fl/fl and Hif-2α^fl/fl mice.

Conclusion: Our study showed that inhibition of HIF-2α decreases bone mass by inhibiting the osteogenic differentiation and increasing the adipogenic differentiation of BMSCs through inhibition of mTOR signaling in the BM niche.

Keywords: Bone marrow niche; Bone mesenchymal stem cells; Hypoxia-inducible factor-2α; Mechanistic target of rapamycin signaling pathway; Osteogenic/adipogenic differentiation; Osteoporosis.